INNV
InnovAge Holding Corp.
Medical - Care Facilities
Market Cap$1.10B
5Y Perf.-68.7%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
INNV vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
DBVT
DBV Technologies S.A.
Biotechnology
Market Cap$1712.35T
5Y Perf.-62.5%
INNV vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | INNV | DBVT |
|---|---|---|
| Industry | Medical - Care Facilities | Biotechnology |
| Market Cap | $1.10B | $1712.35T |
| Revenue (TTM) | $946M | $0.00 |
| Net Income (TTM) | $-22M | $-168M |
| Gross Margin | 14.8% | — |
| Operating Margin | 1.5% | — |
| Forward P/E | 32.0x | — |
| Total Debt | $101M | $22M |
| Cash & Equiv. | $64M | $194M |
INNV vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
INNV
DBVT
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| InnovAge Holding Co… (INNV) | 100 | 31.3 | -68.7% |
| DBV Technologies S.… (DBVT) | 100 | 37.5 | -62.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INNV vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: INNV leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and recent price momentum and sentiment. DBV Technologies S.A. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
INNV
InnovAge Holding Corp.
The Income Pick
INNV carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 1.66
- Rev growth 11.8%, EPS growth -37.5%, 3Y rev CAGR 6.9%
- -66.6% 10Y total return vs DBVT's -87.0%
Best for: income & stability and growth exposure
DBVT
DBV Technologies S.A.
The Defensive Pick
DBVT is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.26, Low D/E 12.8%, current ratio 3.67x
- Beta 1.26, current ratio 3.67x
- 0.3% margin vs INNV's -2.3%
Best for: sleep-well-at-night and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | INNV | 11.8% revenue growth vs DBVT's -100.0% |
| Quality / Margins | DBVT | 0.3% margin vs INNV's -2.3% |
| Stability / Safety | DBVT | Beta 1.26 vs INNV's 1.66, lower leverage |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | INNV | +147.9% vs DBVT's +110.4% |
| Efficiency (ROA) | INNV | -4.1% ROA vs DBVT's -89.0% |
INNV vs DBVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
INNV vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLINNVLAGGINGDBVT
DBVTDBV Technologies S.A.
2leads
INNVInnovAge Holding Corp.
2leads
6 Total Categories
CATEGORYLEADERvs DBVTMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
DBVT1/1
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
INNV5/8
Total Returns1Y, 3Y, 5Y total returns with dividends
INNV6/6
Risk & VolatilityBeta, volatility, and downside exposure
DBVT2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
DBVT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
INNV and DBVT operate at a comparable scale, with $946M and $0 in trailing revenue.
| Metric | INNVInnovAge Holding … | DBVTDBV Technologies … |
|---|---|---|
| RevenueTrailing 12 months | $946M | $0 |
| EBITDAEarnings before interest/tax | $4M | -$112M |
| Net IncomeAfter-tax profit | -$22M | -$168M |
| Free Cash FlowCash after capex | $39M | -$151M |
| Gross MarginGross profit ÷ Revenue | +14.8% | — |
| Operating MarginEBIT ÷ Revenue | +1.5% | — |
| Net MarginNet income ÷ Revenue | -2.3% | — |
| FCF MarginFCF ÷ Revenue | +4.1% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.5% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -161.3% | +91.5% |
DBVT leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
Evenly matched — INNV and DBVT each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | INNVInnovAge Holding … | DBVTDBV Technologies … |
|---|---|---|
| Market CapShares × price | $1.1B | $1712.35T |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $1712.35T |
| Trailing P/EPrice ÷ TTM EPS | -36.73x | -0.76x |
| Forward P/EPrice ÷ next-FY EPS est. | 32.03x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 1.28x | — |
| Price / BookPrice ÷ Book value/share | 4.16x | 0.66x |
| Price / FCFMarket cap ÷ FCF | 41.22x | — |
Evenly matched — INNV and DBVT each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
INNV leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
INNV delivers a -8.2% return on equity — every $100 of shareholder capital generates $-8 in annual profit, vs $-130 for DBVT. DBVT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to INNV's 0.38x. On the Piotroski fundamental quality scale (0–9), INNV scores 6/9 vs DBVT's 4/9, reflecting solid financial health.
| Metric | INNVInnovAge Holding … | DBVTDBV Technologies … |
|---|---|---|
| ROE (TTM)Return on equity | -8.2% | -130.2% |
| ROA (TTM)Return on assets | -4.1% | -89.0% |
| ROICReturn on invested capital | -6.8% | — |
| ROCEReturn on capital employed | -7.1% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.38x | 0.13x |
| Net DebtTotal debt minus cash | $37M | -$172M |
| Cash & Equiv.Liquid assets | $64M | $194M |
| Total DebtShort + long-term debt | $101M | $22M |
| Interest CoverageEBIT ÷ Interest expense | 5.96x | -189.82x |
INNV leads this category, winning 5 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
INNV leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in INNV five years ago would be worth $3,150 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, INNV leads with a +147.9% total return vs DBVT's +110.4%. The 3-year compound annual growth rate (CAGR) favors INNV at 7.6% vs DBVT's 6.2% — a key indicator of consistent wealth creation.
| Metric | INNVInnovAge Holding … | DBVTDBV Technologies … |
|---|---|---|
| YTD ReturnYear-to-date | +55.7% | +4.9% |
| 1-Year ReturnPast 12 months | +147.9% | +110.4% |
| 3-Year ReturnCumulative with dividends | +24.5% | +19.7% |
| 5-Year ReturnCumulative with dividends | -68.5% | -69.1% |
| 10-Year ReturnCumulative with dividends | -66.6% | -87.0% |
| CAGR (3Y)Annualised 3-year return | +7.6% | +6.2% |
INNV leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
DBVT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DBVT is the less volatile stock with a 1.26 beta — it tends to amplify market swings less than INNV's 1.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | INNVInnovAge Holding … | DBVTDBV Technologies … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.66x | 1.26x |
| 52-Week HighHighest price in past year | $10.68 | $26.18 |
| 52-Week LowLowest price in past year | $2.85 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +75.7% | +76.3% |
| RSI (14)Momentum oscillator 0–100 | 50.2 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 291K | 252K |
DBVT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates INNV as "Hold" and DBVT as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs -15.8% for INNV (target: $7).
| Metric | INNVInnovAge Holding … | DBVTDBV Technologies … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $6.80 | $46.33 |
| # AnalystsCovering analysts | 8 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
DBVT leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). INNV leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.
Best OverallInnovAge Holding Corp. (INNV)Leads 2 of 6 categories
Loading custom metrics...
INNV vs DBVT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is INNV or DBVT a better buy right now?
Analysts rate DBV Technologies S.
A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — INNV or DBVT?
Over the past 5 years, InnovAge Holding Corp.
(INNV) delivered a total return of -68. 5%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: INNV returned -66. 6% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — INNV or DBVT?
By beta (market sensitivity over 5 years), DBV Technologies S.
A. (DBVT) is the lower-risk stock at 1. 26β versus InnovAge Holding Corp. 's 1. 66β — meaning INNV is approximately 32% more volatile than DBVT relative to the S&P 500. On balance sheet safety, DBV Technologies S. A. (DBVT) carries a lower debt/equity ratio of 13% versus 38% for InnovAge Holding Corp. — giving it more financial flexibility in a downturn.
04Which is growing faster — INNV or DBVT?
On earnings-per-share growth, the picture is similar: InnovAge Holding Corp.
grew EPS -37. 5% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — INNV or DBVT?
DBV Technologies S.
A. (DBVT) is the more profitable company, earning 0. 0% net margin versus -3. 6% for InnovAge Holding Corp. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DBVT leads at 0. 0% versus -3. 5% for INNV. At the gross margin level — before operating expenses — INNV leads at 68. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is INNV or DBVT more undervalued right now?
Analyst consensus price targets imply the most upside for DBVT: 131.
8% to $46. 33.
07Which pays a better dividend — INNV or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is INNV or DBVT better for a retirement portfolio?
For long-horizon retirement investors, DBV Technologies S.
A. (DBVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 26)). InnovAge Holding Corp. (INNV) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DBVT: -87. 0%, INNV: -66. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between INNV and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.